Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2022.01.05
2022年第一次暂时股东大会决议通告
2022.01.05
关于全资子公司为上市公司提供反担保的通告
2021.12.11
关于调解向全资子公司Hepalink USA Inc增资计划的通告
2021.12.11
关于公司面向专业投资者果真刊行公司债券预案的通告
2021.12.11
关于召开2022年第一次暂时股东大会的通知通告
2021.12.11
关于向全资子公司天道医药(香港)有限公司增资的通告
2021.12.11
关于延伸员工持股妄想存续期的通告
2021.12.11
关于为面向专业投资者果真刊行公司债券增添增信步伐并 提供反担保的通告
2021.12.11
第五届董事会第十五次聚会决议通告
2021.12.11
第五届监事会第八次聚会决议通告
第一页
上一页
13
14
15
16
17
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】